Tuesday 3, March 2020
7:00pm – 8:30pm AEDT
ACRRM: 1.5 hours under the Educational Activities Category applied for
NEW BONUS TOPIC: CORONAVIRUS UPDATE
Protecting your Practice, Travel Advice, and Possible Treatments
Dr Bernard Hudson will discuss safety in your practice, and while travelling, in an interview with GP and RACGP president Dr Harry Nespolon
Clinical microbiologist and infectious diseases physician Dr Bernard Hudson will tackle several issues of key importance for General Practitioners as Coronavirus (COVID-19) continues to ramp up here and overseas. Dr Hudson will cover the latest on protective equipment and techniques to protect your practice, how to stay safe while travelling, and some of the potential treatments for COVID-19.
Safe and Responsible Use of Traditional Opioids in GP
Prof Milton Cohen: Specialist Pain Medicine Physician and Rheumatologist, St Vincent’s Sydney
Opioid analgesics continue to have an important role in the management of non-cancer chronic pain, however “the opioid crisis” has shown us that it must be done more carefully, with full awareness of both the benefits and risks. Prof Cohen is one of Australia’s leading pain management experts, and in this talk he will describe a practical framework for GPs to use when considering the use of traditional opioids and subsequent initiation, monitoring and communication with the patient on the treatment journey. With this systematic approach there is no need to throw the baby out with the bathwater.
Iron Metabolism, Iron Deficiency, Its Assessment and Management in Primary Care
Dr Pradeep Jayasuriya: GP; Past Director of Research, RACGP WA
Iron deficiency is the most common nutritional disorder in the world affecting 25% of the world’s population, yet it remains a challenge to detect and treat effectively. It can affect anyone at any age and can present in myriad ways making detection difficult. In recent times treatment guidelines have changed, with reduced thresholds for diagnosis and an emphasis on earlier treatment. Oral iron therapy remains the mainstay of therapy but varying dosage schedules and poor adherence is a common problem. Nevertheless, some simple strategies that can be implemented at a primary care level can improve adherence substantially and improve the outcomes for patients.
The Role of Progestogens in HRT and Management of Menopausal Symptoms
Prof Rod Baber: Clinical Professor of Obstetrics and Gynaecology, Sydney Medical School, The University of Sydney; Head of Menopause and Menstrual Disorders Clinic, Royal North Shore Hospital
For approximately 30% of women, menopausal symptoms are severe and may adversely affect quality of life, general health, and professional and family life. For these women, HRT might be the most suitable option to minimize the debilitation and thus significantly improve quality of life. It’s important for GPs to understand the different clinical effects, as well as the risks, of progestins compared to progesterone within HRT regimens so that the patient can experience the best possible outcome, particularly with regard to breast cancer risk.